| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | ARUNA BIO INC | 150 COLLINS INDUSTRIAL BLVD | ATHENS | GA | 30601-1516 | CLARKE | USA | R43DA064200 | Neural exosome therapeutics for treating opioid-induced brain hypoxia injuries | 000 | 1 | NIH | 12/4/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $399,997 ) |
| | 2025 | 2025 | ARUNA BIO INC | 150 COLLINS INDUSTRIAL BLVD | ATHENS | GA | 30601-1516 | CLARKE | USA | R43DA064200 | Neural exosome therapeutics for treating opioid-induced brain hypoxia injuries | 000 | 1 | NIH | 8/7/2025 | $399,997 |
|
| Issue Date FY: 2024 ( Subtotal = $333,261 ) |
| | 2024 | 2024 | ARUNA BIO INC | 150 COLLINS INDUSTRIAL BLVD | ATHENS | GA | 30601-1516 | CLARKE | USA | R41NS122704 | Neural Stem Cell Extracellular Vesicle Treatment for Traumatic Brain Injury | 000 | 2 | NIH | 6/26/2024 | $333,261 |
|
| Issue Date FY: 2023 ( Subtotal = $347,398 ) |
| | 2023 | 2023 | ARUNA BIO, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 000 | 4 | NIH | 9/22/2023 | $347,398 |
| | 2023 | 2022 | ARUNA BIO, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R41NS122704 | Neural Stem Cell Extracellular Vesicle Treatment for Traumatic Brain Injury | 000 | 1 | NIH | 8/2/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $346,150 ) |
| | 2022 | 2022 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R41NS122704 | Neural Stem Cell Extracellular Vesicle Treatment for Traumatic Brain Injury | 000 | 1 | NIH | 5/24/2022 | $346,150 |
| | 2022 | 2020 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 000 | 3 | NIH | 6/23/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 000 | 3 | NIH | 2/5/2021 | $0 |
| | 2021 | 2020 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 001 | 3 | NIH | 9/4/2021 | $0 |
| | 2021 | 2017 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43NS103596 | Human Neural Cell Exosomes as a therapeutic treatment for stroke | 000 | 1 | NIH | 12/8/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,304,996 ) |
| | 2020 | 2020 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 001 | 3 | NIH | 8/18/2020 | $1,304,996 |
| | 2020 | 2019 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 000 | 2 | NIH | 4/9/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $2,880,097 ) |
| | 2019 | 2019 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R44NS103596 | Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke | 000 | 2 | NIH | 9/18/2019 | $2,880,097 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43ES026944 | Cryopreserved Adherent Neural Cell Assay Plates | 000 | 1 | NIH | 4/23/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $499,990 ) |
| | 2017 | 2017 | ARUNA BIOMEDICAL, INC. | 425 RIVER RD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43NS103596 | Human Neural Cell Exosomes as a therapeutic treatment for stroke | 000 | 1 | NIH | 8/21/2017 | $499,990 |
|
| Issue Date FY: 2016 ( Subtotal = $225,000 ) |
| | 2016 | 2016 | ARUNA BIOMEDICAL INC | 425 RIVER ROAD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43ES026944 | Cryopreserved Adherent Neural Cell Assay Plates | 000 | 1 | NIH | 5/19/2016 | $225,000 |
|
| Issue Date FY: 2013 ( Subtotal = $600,170 ) |
| | 2013 | 2013 | ARUNA BIOMEDICAL INC | 425 RIVER ROAD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43ES023530 | METABOLIC ASSAY UTILIZING NEURODEVELOPMENTAL CELLS DERIVED FROM HUMAN PLURIPOTENT | 000 | 1 | NIH | 8/28/2013 | $224,956 |
| | 2013 | 2013 | ARUNA BIOMEDICAL INC | 425 RIVER ROAD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43NS080407 | ADHESION SIGNATURE-BASED, LABEL-FREE ISOLATION OF PLURIPOTENT STEM CELL DERIVED N | 000 | 2 | NIH | 9/3/2013 | $375,214 |
|
| Issue Date FY: 2012 ( Subtotal = $331,012 ) |
| | 2012 | 2012 | ARUNA BIOMEDICAL INC | 425 RIVER ROAD | ATHENS | GA | 30602-1506 | CLARKE | USA | R43NS080407 | ADHESION SIGNATURE-BASED, LABEL-FREE ISOLATION OF PLURIPOTENT STEM CELL DERIVED N | 000 | 1 | NIH | 9/24/2012 | $331,012 |
|
| Issue Date FY: 2008 ( Subtotal = $189,593 ) |
| | 2008 | 2008 | ARUNA BIOMEDICAL INC | 425 RIVER ROAD | ATHENS | GA | 30602 | CLARKE | USA | R43HD058394 | HUMAN EMBRYONIC STEM CELL KIT FOR DERIVING MESENCHYMAL STEM CELL LINEAGES | 000 | 1 | NIH | 6/27/2008 | $189,593 |
|
|
